Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Shareholders of cannabis company Tilray Inc. voted in favour of a proposed merger with rival Aphria Inc. on Friday, in a transaction that will pave the way for the creation of the world’s largest cannabis company by revenue, which will operate under Tilray’s name.

The company will release details of the vote on Monday morning, but a source with knowledge of the meeting confirmed to The Globe and Mail that the merger was approved by shareholders. The Globe is not identifying the source because they are not authorized to speak publicly about the deal.

The combined entity will trade on the Toronto Stock Exchange, and be led by Aphria chief executive Irwin Simon. Tilray CEO Brendan Kennedy will remain on the board of the new company.

Story continues below advertisement

Shares of Tilray and Aphria, which have been trading in tandem since the deal was announced last December, both dipped slightly immediately following news of the approved deal. Aphria closed at $18.88 on the TSX, down just 4 cents for the day, but still up more than 90 per cent since December. Tilray’s stock, currently listed on the Nasdaq exchange, closed at US$18.34, down 31 US cents, but up 120 per cent over the past four months.

Aphria’s stock also trades on Nasdaq, but it will be delisted from that exchange on May 3. The deal is expected to close by the end of the second quarter of 2021.

The transaction is effectively a takeover of Tilray by Aphria, with Aphria shareholders receiving 0.8381 of a share of Tilray common stock for each of their Aphria shares. Aphria shareholders will therefore own 62 per cent of the new company, while Tilray stockholders will own the remaining 38 per cent.

Company filings show that when the two CEOs first discussed the deal in February, 2020, it was structured more as a merger of equals, with shareholders of Tilray owning 56 per cent of the combined company and Aphria shareholders owning 44 per cent. Mr. Kennedy would have served as CEO and Mr. Simon as executive chairman. At that point, Tilray was trading much higher than Aphria.

But waning sales and a broader investor sell-off in the Canadian cannabis sector pummelled Tilray’s stock for most of 2020, leaving Aphria in a more competitive bargaining position during negotiations.

Friday’s approval of the merger by Tilray shareholders comes after weeks of uncertainty about whether the transaction would even go through. Tilray initially scheduled a shareholder meeting to vote on the deal on April 16, but delayed it by two weeks, in part because the company had struggled to get the required minimum number of shareholders to attend.

Indeed, company filings indicate this issue was first flagged by Tilray’s proxy solicitation partner, MacKenzie Partners Inc., in an April 8 meeting, citing the number of retail stockholders and a large “dead block” of shares as the main obstacles in achieving quorum.

Story continues below advertisement

To circumvent the issue, Tilray’s board, with advice from its lawyers, voted on April 15 to amend the company’s bylaws so just one-third of its shareholders needed to approve the deal, as opposed to a majority of them.

It is still unclear how many shareholder votes resulted in the deal being pushed through. Aphria’s shareholders approved the merger on April 14 with 99.38 per cent of shares represented at the meeting voting in favour of the reverse acquisition.

Aphria is the bigger company in terms of quantity of cannabis produced and revenue generated from cannabis sold domestically. Aphria’s revenue in 2020 was approximately $600-million, while Tilray’s was almost US$200-million.

From Tilray’s perspective, the idea behind combining brands was to leverage Aphria’s scale of production, given that Tilray continues to rely on the wholesale cannabis market for supply. Analysts expect the new company to capture 20 per cent of cannabis demand in Canada.

“It’s a classic industrial strategy for the No. 2 and No. 3 players to merge and contest the No. 1 player for market leadership. That’s what the Aphria Tilray merger is about, in Canada,” said Chris Damas, a cannabis analyst and author of The BCMI Report.

Both companies have incurred massive losses over the years, in part from overpaying for high-end cultivation facilities that ended up being underutilized in the face of a domestic supply glut and lower-than-expected consumer demand. In 2020, Aphria reported a net loss of $585-million, while Tilray’s net loss was approximately $330-million.

Story continues below advertisement

Aphria and Tilray have substantial operations in Germany and Portugal, respectively, and will maintain facilities in those two countries. In the U.S., Aphria owns the craft beer company Sweetwater Brewing and plans to launch a CBD-infused beverage line as the country inches toward federal legalization under Democratic President Joe Biden. Tilray owns the Winnipeg-based hemp company Manitoba Harvest, which, to a large extent, made up for Tilray’s weak cannabis sales for most of 2019 and 2020.

By leveraging each other’s assets, the two entities hope to deliver annual pretax cost savings of $100-million within two years of the merger, according to an earlier statement from both companies.

Your time is valuable. Have the Top Business Headlines newsletter conveniently delivered to your inbox in the morning or evening. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies